Study of Oral Navitoclax Tablet in Combination With Oral Ruxolitinib Tablet Versus Best Available Therapy to Assess Change in Spleen Volume in Adult Participants With Relapsed/Refractory Myelofibrosis
PHASE3
Myelofibrosis (MF) is a rare blood cancer, notable for scarring of the bone...
Safety and Tolerability Study of Mivebresib Tablet Alone or in Combination With Ruxolitinib Tablet or Navitoclax Tablet in Adult Participants With Myelofibrosis
PHASE1
Myelofibrosis (MF) is a bone marrow illness that affects blood-forming tiss...
A Study Evaluating Safety and Tolerability, and Pharmacokinetics of Navitoclax Monotherapy and in Combination With Ruxolitinib in Participants With Myeloproliferative Neoplasm
PHASE1
There are 5 parts to this study for which the primary objectives are to eva...